Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

A Multicenter Study to Validate the Reproducibility of MSI Testing With a Panel of 5 Quasimonomorphic Mononucleotide Repeats

Nardon, Ermanno PhD*,†; Glavač, Damjan PhD; Benhattar, Jean PhD§; Groenen, Patricia J.T.A. PhD; Höfler, Gerald MD; Höfler, Heinz MD; Jung, Andreas PhD**; Keller, Gisela PhD; Kirchner, Thomas MD**; Lessi, Francesca PhD††; Ligtenberg, Marjolijn J.L. PhD‡‡; Mazzanti, Chiara Maria PhD††; Winter, Gerlinde PhD; Stanta, Giorgio MD*,†

doi: 10.1097/PDM.0b013e3181db67af
Original Articles
Buy

Microsatellite instability (MSI) testing in clinics is becoming increasingly widespread; therefore, there is an urgent need for methodology standardization and the availability of quality control. This study is aimed to assess the interlaboratory reproducibility of MSI testing in archive samples by using a panel of 5 recently introduced, mononucleotide repeats (MNR). The quality control involved 8 European institutions. Participants were supplied with DNA extracted from 15 archive colon carcinoma samples and from the corresponding normal tissues. Every group was asked to assess the MSI status of the samples by using the BAT25, BAT26, NR21, NR24, and NR27 mononucleotide markers. Four institutions repeated the analysis using the NCI reference panel to confirm the results obtained with the MNR markers. The overall concordance among institutions for MSI analyses at single locus level was 97.7% when using the MNR panel and 95.0% with the NCI one. The laboratories obtained a full agreement in scoring the MSI status of each patient sample, both using the mononucleotide and the NCI marker sets. With the NCI marker set, however, concordance was lowered to 85.7% when considering the MSI-Low phenotype. Concordance between the 2 panels in scoring the MSI status of each sample was complete if no discrimination was made between MSI-Stable and MSI-L, whereas it dropped to 76.7% if MSI-L was considered. In conclusion, the use of the MNR panel seems to be a robust approach that yields a very high level of reproducibility. The results obtained with the 5 MNR are diagnostically consistent with those obtained by the use of the NCI markers, except for the MSI-Low phenotype.

*Department of A.C.A.D.E.M., University of Trieste, Trieste, Italy

International Centre for Genetic Engineering and Biotechnology, Padriciano, Trieste, Italy

†Istitute of Anatomic Pathology, Laboratory of Molecular Pathology, University of Pisa, Pisa, Italy

Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

§Institute of Pathology CHUV and University of Lausanne, Lausanne, Switzerland

Department of Pathology, Radboud University Nijmegen Medical Centre, SZ Nijmegen, The Netherlands

‡Human Genetics, Radboud University Nijmegen Medical Centre, HB Nijmegen, The Netherlands

Labor für molekularpathologische Diagnostik, Institut für Pathologie, Medical University of Graz, A- Graz, Austria

Institute of Pathology, Technische Universität München, Munich, Germany

**Pathologisches Institut der Ludwig-Maximilians Universität München, Munich, Germany

Reprints: Giorgio Stanta, MD, Department of A.C.A.D.E.M, University of Trieste, Cattinara Hospital, Surgical Pathology Bldg, Strada di Fiume 447, I-34149 Trieste, Italy (e-mail: stanta@icgeb.org).

© 2010 Lippincott Williams & Wilkins, Inc.